News
While others played safe, Shanghvi bet on complex generics and specialty pharma, and rode a wave of acquisitions to make Sun ...
10h
Bright Side on MSN14 Signs Your Body Might Be Sensitive to GlutenGluten might appear harmless, but for some individuals, it can silently provoke significant health problems. Often lacking ...
8h
News-Medical.Net on MSNHonorHealth Research Institute treats first patient in global trial targeting aggressive melanomaHonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a ...
Recent years have seen significant advancements in UC treatment, offering renewed hope for patients seeking effective and ...
The condition, recessive dystrophic epidermolysis bullosa, causes chronic wounds and has an 84% mortality rate by age 40.
Third Eye Blind, Akon, Brantley Gilbert, Credence Clearwater Revival frontman John Fogerty and La Arrolladora Banda El Limón de René Camacho will headline Hammond's Festival of the Lakes this year.
12h
Medpage Today on MSNFDA OKs New Gene Therapy for Debilitating Skin ConditionPatients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...
Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results